Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism (Q38715468)

5 September 2017

1 reference

title

Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism (English)

1 reference

amyotrophic lateral sclerosis and frontotemporal dementia

5 September 2017

main subject

0 references

amyotrophic lateral sclerosis

0 references

dementia

0 references

frontotemporal dementia

1 reference

5

1 reference

5 September 2017

6

1 reference

5 September 2017

Muireann Irish

2

0 references

Glenda Halliday

object named as

Glenda M Halliday

series ordinal

4

0 references

Olivier Piguet

object named as

Olivier Piguet

series ordinal

3

0 references

Matthew C Kiernan

series ordinal

8

object named as

Matthew C Kiernan

1 reference

5 September 2017

7

John R Hodges

1 reference

5 September 2017

1

Rebekah M Ahmed

1 reference

5 September 2017

publication date

25 January 2016

1 reference

5 September 2017

1 reference

5 September 2017

volume

15

1 reference

5 September 2017

issue

3

1 reference

5 September 2017

page(s)

332-342

1 reference

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

The relationship between diabetes mellitus and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Hypothalamic-endocrine aspects in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Weight loss in Huntington disease increases with higher CAG repeat number

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Weight loss in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Adiposity and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Insulin and neurodegenerative disease: shared and specific mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

The overlap of amyotrophic lateral sclerosis and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Frontotemporal lobar degeneration with motor neuron disease: a clinical and pathological spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Clinical entity of frontotemporal dementia with motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Controversies and priorities in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Prevalence and patterns of cognitive impairment in sporadic ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Semantic dementia: a unique clinicopathological syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Classification of primary progressive aphasia and its variants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Motor neuron dysfunction in frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Familial frontotemporal dementia and amyotrophic lateral sclerosis associated with the C9ORF72 hexanucleotide repeat

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Amyotrophic lateral sclerosis--a model of corticofugal axonal spread

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Stages of pTDP-43 pathology in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Thiamine deficiency in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: A prospective interventional study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Effect of nutritional supplementation with milk whey proteins in amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Energy metabolism in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Hypermetabolism in ALS patients: an early and persistent phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Mitochondrial involvement in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Hypolipidemia in patients with amyotrophic lateral sclerosis: a possible gender difference?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Lower serum lipid levels are related to respiratory impairment in patients with ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

THE ASSOCIATION OF AMYOTROPHIC LATERAL SCLEROSIS (MOTOR NEURON DISEASE) AND CARBOHYDRATE INTOLERANCE, A CLINICAL STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

ALS disease onset may occur later in patients with pre-morbid diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Insulin resistance in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Association between diabetes and amyotrophic lateral sclerosis in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Risk of Amyotrophic Lateral Sclerosis in Patients With Diabetes: A Nationwide Population-Based Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Nutritional status is a prognostic factor for survival in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Lifetime physical activity and the risk of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Premorbid weight, body mass, and varsity athletics in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Premorbid body mass index and risk of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Nutritional status and risk of amyotrophic lateral sclerosis in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Changes in dietary or eating behavior in frontotemporal dementia versus Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Distinct behavioural profiles in frontotemporal dementia and semantic dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Quantifying the eating abnormalities in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Characteristics of abnormal eating behaviours in frontotemporal lobar degeneration: a cross-cultural survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Dysphagia in patients with frontotemporal lobar dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Behavioral disorders in the frontal and temporal variants of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Self-projection and the default network in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Anatomical correlates of reward-seeking behaviours in behavioural variant frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Flavour identification in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

The hormonal control of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

The hunger genes: pathways to obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Eating and hypothalamus changes in behavioral-variant frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Eating behavior in frontotemporal dementia: Peripheral hormones vs hypothalamic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Neuroendocrine regulation of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Unraveling the brain regulation of appetite: lessons from genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Neurobiology of food intake in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

The melanocortin antagonist AgRP (83-132) increases appetitive responding for a fat, but not a carbohydrate, reinforcer.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Moderate high fat diet increases sucrose self-administration in young rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Rodent models of TDP-43: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Systemic metabolism in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Cardiovascular risk factors and frontotemporal dementia: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Motor neuron disease-frontotemporal dementia: a clinical continuum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Body mass index delineates ALS from FTD: implications for metabolic health

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Survival in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Survival in frontotemporal lobar degeneration in a Korean population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900380-4

7 January 2021

10.1016/S1474-4422(15)00380-4

Identifiers

DOI

1 reference

release_dcj5e2mx5bag7af7l6muv5v6ri

5 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dcj5e2mx5bag7af7l6muv5v6ri

24 November 2022

mapped directly with Wikidata item

1 reference